Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

The medicine's popularity has been driven by endorsements from celebrities and influencers. Read more at straitstimes.com.

Emerging research suggests that certain diabetes medications could offer benefits beyond blood sugar control, potentially ...

GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...